You are here

AstraZeneca heart drug fails in key stroke trial

Wednesday, March 23, 2016 - 16:00

DRUG23032016.jpg
[LONDON] AstraZeneca said on Wednesday its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial, dealing a blow to a product viewed as an important driver of future sales and profits.

[LONDON] AstraZeneca said on Wednesday its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial, dealing a blow to a product viewed as an important driver of future sales and profits.

The trial found that Brilinta was not significantly better than aspirin, the current standard of care, in preventing recurrent attacks in the 90 days after patients suffer a stroke.

REUTERS

sentifi.com

Market voices on:

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom